Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients With Chronic Low Back Pain
ShockEffect
1 other identifier
interventional
400
1 country
1
Brief Summary
Analysis of the effectiveness of radial shock wave therapy as part of a multimodal pain therapy in the inpatient setting. Different therapy protocols are compared in previously non-operated and in previously operated patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2022
CompletedFirst Posted
Study publicly available on registry
April 4, 2022
CompletedStudy Start
First participant enrolled
September 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 7, 2025
CompletedApril 6, 2025
April 1, 2025
2.3 years
March 15, 2022
April 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in Numeric Rating Scale (NRS)
Pain intensity measured by Numeric Rating Scale (NRS) \- 11-point scale / min. 0 (better outcome) / max. 10 (worse outcome)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
Secondary Outcomes (9)
change in Oswestry Disability Index (ODI)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in European Quality of Life 5 Dimensions (EQ5D)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in Pain Self-Efficacy Questionnaire (PSEQ)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in Patient Health Questionnaire-9 (PHQ-9)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in Perseverative Thinking Questionnaire (PTQ)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
- +4 more secondary outcomes
Study Arms (8)
PreviousSurgery(PrevSurg)_YES/rESWT_4000
ACTIVE COMPARATORPrevious Surgery on degenerative pathology in lumbar spine: YES rESWT: 4000 pulse, 20 Hz
PrevSurg_YES/rESWT_500
ACTIVE COMPARATORPrevious Surgery on degenerative pathology in lumbar spine: YES rESWT: 500 pulse, 2 Hz
PrevSurg_YES/rESWT_no
ACTIVE COMPARATORPrevious Surgery on degenerative pathology in lumbar spine: YES rESWT: no
PrevSurg_YES/rESWT_deny
ACTIVE COMPARATORPrevious Surgery on degenerative pathology in lumbar spine: YES rESWT: denied
PrevSurg_NO/rESWT_4000
ACTIVE COMPARATORPrevious Surgery on degenerative pathology in lumbar spine: NO rESWT: 4000 pulse, 20 Hz
PrevSurg_NO/rESWT_500
ACTIVE COMPARATORPrevious Surgery on degenerative pathology in lumbar spine: NO rESWT: 500 pulse, 2 Hz
PrevSurg_NO/rESWT_no
ACTIVE COMPARATORPrevious Surgery on degenerative pathology in lumbar spine: NO rESWT: no
PrevSurg_NO/rESWT_deny
ACTIVE COMPARATORPrevious Surgery on degenerative pathology in lumbar spine: NO rESWT: denied
Interventions
application of radial extracorporeal shockwave therapy (rESWT) with 4000 pulses and 20 Hz
application of radial extracorporeal shockwave therapy (rESWT) with 500 pulses and 2 Hz
standard multimodal pain therapy
Eligibility Criteria
You may qualify if:
- chronic lumbar back pain of min 3 months duration
You may not qualify if:
- radicular pain of higher intensity than chronic low back pain (cLBP)
- new neurologic deficits
- anticoagulant therapy
- new trauma to the lumbar spine
- spine bacterial infection
- spine tumor
- pregnancy
- coagulation disorder
- fibromyalgia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinik Blankenstein
Hattingen, 45527, Germany
Related Publications (1)
Lange T, Deventer N, Gosheger G, Lampe LP, Bockholt S, Schulze Boevingloh A, Schulte TL. Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain-Randomized Controlled Trial. J Clin Med. 2021 Nov 26;10(23):5569. doi: 10.3390/jcm10235569.
PMID: 34884271RESULT
Related Links
Study Officials
- STUDY DIRECTOR
Tobias L Schulte, Prof
Department of Orthopaedics and Trauma Surgery, St. Josef-Hospital, Ruhr-University Bochum
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 15, 2022
First Posted
April 4, 2022
Study Start
September 18, 2022
Primary Completion
December 31, 2024
Study Completion
December 7, 2025
Last Updated
April 6, 2025
Record last verified: 2025-04